Cogent Biosciences (COGT)
(Delayed Data from NSDQ)
$7.86 USD
+0.10 (1.29%)
Updated Dec 24, 2024 01:00 PM ET
After-Market: $7.85 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/24/2025
Time: -- |
12/2024 | $-0.59 | -8.74% |
Earnings Summary
For their last quarter, Cogent Biosciences (COGT) reported earnings of -$0.64 per share, missing the Zacks Consensus Estimate of -$0.55 per share. This reflects a negative earnings surprise of 16.36%. Look out for COGT's next earnings release expected on February 24, 2025. For the next earning release, we expect the company to report earnings of -$0.59 per share, reflecting a year-over-year increase of 6.35%.
Earnings History
Price & Consensus
Zacks News for COGT
COGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
COGT FAQs
Based on past history, Zacks believes Cogent Biosciences, Inc. (COGT) will report their next quarter earnings on February 24, 2025. For the next earning release, we expect the company to report earnings of -0.59 per share, reflecting a year-over-year increase of 6.35.
Based on past history, Zacks believes Cogent Biosciences, Inc. (COGT) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on February 24, 2025.
The Zacks Consensus Estimate for Cogent Biosciences, Inc. (COGT) for the quarter ending in December 2024 is $-0.59 a share. We expect Cogent Biosciences, Inc. to miss by -8.74%.
In the earnings report for the quarter ending in June 2024, Cogent Biosciences, Inc. (COGT) announced earnings of $-0.59 per share versus the Zacks Consensus Estimate of $-0.55 per share, representing a surprise of 7.27%.